Pictet & Cie (Europe) Sa Johnson & Johnson Transaction History

Pictet & Cie (Europe) Sa

$4.19 Billion
Q3 2024

A detailed history of Pictet & Cie (Europe) Sa transactions in Johnson & Johnson stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 11,743 shares of JNJ stock, worth $1.82 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,743

Previous 12,363 5.01%

Holding current value

$1.82 Million

Previous $1.81 Million 5.37%

% of portfolio

0.05%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$145.48 - $167.38 $90,197 - $103,775	-620 Reduced 5.01%	11,743 $1.9 Million
Q2 2024 Jul 25, 2024	SELL	$144.38 - $157.78 $693,168 - $757,501	-4,801 Reduced 27.97%	12,363 $1.81 Million
Q1 2024 May 07, 2024	SELL	$155.22 - $162.74 $912,848 - $957,073	-5,881 Reduced 25.52%	17,164 $2.72 Million
Q4 2023 Feb 09, 2024	SELL	$145.6 - $158.88 $116,625 - $127,262	-801 Reduced 3.36%	23,045 $3.61 Million
Q3 2023 Nov 02, 2023	BUY	$155.75 - $174.48 $78,498 - $87,937	504 Added 2.16%	23,846 $3.71 Million
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $444,528 - $478,396	-2,880 Reduced 10.98%	23,342 $3.86 Million
Q1 2023 May 01, 2023	BUY	$151.05 - $180.26 $211,772 - $252,724	1,402 Added 5.65%	26,222 $4.06 Million
Q4 2022 Feb 08, 2023	SELL	$160.2 - $179.79 $148,986 - $167,204	-930 Reduced 3.61%	24,820 $0
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $31.7 Million - $35.3 Million	-196,632 Reduced 88.42%	25,750 $4.21 Billion
Q2 2022 Aug 05, 2022	BUY	$168.19 - $186.01 $1.74 Million - $1.92 Million	10,348 Added 4.88%	222,382 $39.5 Million
Q1 2022 May 04, 2022	SELL	$158.14 - $179.59 $14.7 Million - $16.7 Million	-93,008 Reduced 30.49%	212,034 $37.6 Million
Q4 2021 Feb 02, 2022	SELL	$155.93 - $173.01 $14.7 Million - $16.3 Million	-94,301 Reduced 23.61%	305,042 $52.2 Million
Q3 2021 Nov 10, 2021	SELL	$161.5 - $179.47 $6.42 Million - $7.13 Million	-39,728 Reduced 9.05%	399,343 $64.5 Million
Q2 2021 Aug 11, 2021	BUY	$159.48 - $171.07 $6.7 Million - $7.19 Million	42,020 Added 10.58%	439,071 $72.3 Million
Q1 2021 May 10, 2021	BUY	$153.07 - $170.48 $5.26 Million - $5.86 Million	34,392 Added 9.48%	397,051 $65.3 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $112,567 - $129,208	821 Added 0.23%	362,659 $57.1 Million
Q3 2020 Nov 10, 2020	BUY	$140.38 - $153.83 $1.05 Million - $1.15 Million	7,486 Added 2.11%	361,838 $53.9 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $497,077 - $600,113	3,859 Added 1.1%	354,352 $49.8 Million
Q1 2020 Apr 30, 2020	BUY	$111.14 - $153.99 $22.2 Million - $30.7 Million	199,639 Added 132.34%	350,493 $46 Million
Q4 2019 Jan 31, 2020	BUY	$127.5 - $146.44 $2.81 Million - $3.23 Million	22,073 Added 17.14%	150,854 $22 Million
Q3 2019 Nov 08, 2019	BUY	$126.95 - $142.14 $799,658 - $895,339	6,299 Added 5.14%	128,781 $16.7 Million
Q2 2019 Aug 07, 2019	BUY	$131.15 - $144.24 $266,234 - $292,807	2,030 Added 1.69%	122,482 $17.1 Million
Q1 2019 May 01, 2019	BUY	$125.72 - $139.79 $4.71 Million - $5.23 Million	37,440 Added 45.1%	120,452 $16.8 Million
Q4 2018 Jan 31, 2019	BUY	$122.84 - $147.84 $3.51 Million - $4.22 Million	28,567 Added 52.47%	83,012 $10.7 Million
Q3 2018 Nov 07, 2018	BUY	$121.58 - $142.88 $813,978 - $956,581	6,695 Added 14.02%	54,445 $7.52 Million
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $1.37 Million - $1.52 Million	11,500 Added 31.72%	47,750 $5.79 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $3.83 Million - $4.53 Million	-30,600 Reduced 45.77%	36,250 $4.65 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $87,917 - $96,225	-670 Reduced 0.99%	66,850 $9.34 Million
Q3 2017 Nov 07, 2017	BUY	$129.47 - $135.38 $51,788 - $54,152	400 Added 0.6%	67,520 $8.78 Million
Q2 2017 Aug 09, 2017	BUY	N/A	67,120	67,120 $8.88 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account

Pictet & Cie (Europe) Sa Johnson & Johnson Transaction History